Utama › Kanser Prostat › Virginia › Arlington
Kajian klinikal Kanser Prostat di Arlington, VA
17 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute ( Site 0017), Fairfax · 11 mi jauh
- Virginia Cancer Specialists (VCS) ( Site 8004), Fairfax · 11 mi jauh
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Mengambil pesertaFasa 2/3
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Mengambil pesertaFasa 1
- Investigational Site number: 404, Fairfax · 11 mi jauh
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Mengambil pesertaFasa 2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Virginia Cancer Specialists PC, Fairfax · 11 mi jauh
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Mengambil pesertaFasa 1/2
- NEXT Oncology - Virginia, Fairfax · 11 mi jauh
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Mengambil pesertaFasa 1
- Virginia Oncology Associates, Fairfax · 11 mi jauh
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Mengambil peserta
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Mengambil pesertaFasa 1/2
- NEXT Oncology, Fairfax · 11 mi jauh
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT, Virginia, Fairfax · 11 mi jauh
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
Mengambil peserta
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 102, Fairfax · 11 mi jauh
- Research Site 112, Fairfax · 11 mi jauh
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser (semua jenis)48 kajian
- Kanser Payudara46 kajian
- Kanser Ovari46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Kanser Pankreas33 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Payudara Triple-Negatif20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.